Satia Jessie A, McRitchie Susan, Kupper Lawrence L, Halbert Chanita Hughes
Department of Nutrition, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Prev Med. 2006 Jan;42(1):51-9. doi: 10.1016/j.ypmed.2005.10.004. Epub 2005 Nov 17.
To describe attitudes and correlates of intention to take a genetic test for colon cancer in a population-based sample of African-Americans.
African-Americans (n = 658), age 18-70, in North Carolina completed an 11-page questionnaire between June-October 2003 that assessed attitudes (familiarity, perceived benefits and risks, anxiety, and confidentiality) and intention to take a genetic test for colon cancer and various participant characteristics.
Respondents expressed favorable attitudes and high intention regarding genetic testing for colon cancer: 87% would definitely/probably take a genetic test, although only 42% had read/heard a lot or some about genetic testing. Most agreed that genetic test results should be available to healthcare providers (79%) but not to health insurers (62%) or employers (82%). About a third were concerned that genetic testing could lead to discrimination. Correlates of intention differed by sex. Perceived benefits were significantly positively associated with intention among all respondents. However, being married (OR = 2.1, 95% CI: 1.2, 3.7), doctor as the main source of health information (OR = 2.4, 95% CI: 1.4, 3.9), and colon cancer family history (OR = 4.3, 95% CI: 1.6, 11.6) were significant only for women; some college education (OR = 4.1, 95% CI: 1.7, 9.7), importance of sharing test results with relatives (OR = 5.5, 95% CI: 1.6, 18.7), and colon cancer screening history (OR = 3.4, 95% CI: 1.6, 7.5) were only significant for men.
Respondents expressed high interest in genetic testing for colon cancer risk, although confidentiality of test results is a concern. Guidelines and policies for genetic testing specific to African-Americans should be established and future research should examine the prevalence of genetic testing.
描述在一个基于人群的非裔美国人样本中,对结肠癌进行基因检测的态度及意向的相关因素。
2003年6月至10月期间,北卡罗来纳州年龄在18 - 70岁的658名非裔美国人完成了一份11页的问卷,该问卷评估了态度(熟悉程度、感知到的益处和风险、焦虑以及保密性)、对结肠癌进行基因检测的意向以及各种参与者特征。
受访者对结肠癌基因检测表达了积极态度和较高意向:87%肯定/可能会进行基因检测,尽管只有42%对基因检测有较多或一定了解。大多数人同意基因检测结果应提供给医疗服务提供者(79%),但不应提供给健康保险公司(62%)或雇主(82%)。约三分之一的人担心基因检测可能导致歧视。意向的相关因素因性别而异。在所有受访者中,感知到的益处与意向显著正相关。然而,已婚(比值比[OR]=2.1,95%置信区间[CI]:1.2,3.7)、医生作为健康信息的主要来源(OR = 2.4,95% CI:1.4,3.9)以及结肠癌家族史(OR = 4.3,95% CI:1.6,11.6)仅对女性有显著意义;接受过一些大学教育(OR = 4.1,95% CI:1.7,9.7)、与亲属分享检测结果的重要性(OR = 5.5,95% CI:1.6,18.7)以及结肠癌筛查史(OR = 3.4,95% CI:1.6,7.5)仅对男性有显著意义。
受访者对结肠癌风险基因检测表现出高度兴趣,尽管检测结果的保密性令人担忧。应制定针对非裔美国人的基因检测指南和政策,未来研究应调查基因检测的普及率。